BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15888251)

  • 1. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
    Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
    Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow microvascular density and angiogenic growth factors in multiple myeloma.
    Alexandrakis MG; Passam FJ; Ganotakis E; Dafnis E; Dambaki C; Konsolas J; Kyriakou DS; Stathopoulos E
    Clin Chem Lab Med; 2004; 42(10):1122-6. PubMed ID: 15552270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
    Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
    Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG; Passam FH; Pappa CA; Sfiridaki K; Tsirakis G; Damilakis J; Stathopoulos EN; Kyriakou DS
    Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.
    Andersen NF; Standal T; Nielsen JL; Heickendorff L; Borset M; Sørensen FB; Abildgaard N
    Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
    Aguayo A; Kantarjian H; Manshouri T; Gidel C; Estey E; Thomas D; Koller C; Estrov Z; O'Brien S; Keating M; Freireich E; Albitar M
    Blood; 2000 Sep; 96(6):2240-5. PubMed ID: 10979972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the role of angiogenesis in systemic lupus erythematosus.
    Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
    Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes.
    Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki C; Katrinakis G; Tsirakis G; Konsolas J; Stathopoulos EN
    J Mol Histol; 2004 Nov; 35(8-9):857-63. PubMed ID: 15609099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome.
    Albitar M
    Acta Haematol; 2001; 106(4):170-6. PubMed ID: 11815714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma.
    Kara IO; Sahin B; Gunesacar R; Unsal C
    Adv Ther; 2006; 23(4):635-45. PubMed ID: 17050506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.